Featured news
-
External clinical review and independent investigation into missed opportunities started
The external clinical review panel and the independent investigation team have commenced their work and we are providing updates.
-
AI power improves cataract test tool for babies
A device invented by an Addenbrooke’s eye surgeon to detect cataracts in babies is set to be further improved – thanks to artificial intelligence and a team effort with a Cambridgeshire product development consultancy.
-
CUH makes major greenhouse gas cuts
Cambridge University Hospitals NHS Foundation Trust (CUH) has drastically reduced the use of one of the most harmful greenhouse gases across its hospitals.
-
Rare lung collapse disease almost 100 times more common than thought
As many as one in 3,000 people could be carrying a faulty gene that significantly increases their risk of a collapsed lung, according to new estimates from Cambridge researchers. Previous estimates had put this risk closer to one in 200,000 people.
-
You Made a Difference - January 2025
A Breast Unit service manager, and a trauma and orthopaedics coordinator are our You Made a Difference award winners for January 2025.
-
World-first trial indicates immunosuppression may help treat Parkinson's
An early-stage trial highlights the possibility of using immunosuppression treatments to help people with Parkinson's disease.
All news
Showing 20 results
Life-saving ambulance service marks birthday
A life-saving service for critically ill and injured hospital patients celebrates its first birthday today.
You Made a Difference - November 2022
Our winners of You Made a Difference for November 2022 are a staff nurse and a ward manager.
Blood thinning drug does not help patients recover from Covid
A UK-wide trial, led by Addenbrooke’s and the University of Cambridge, has found that a blood thinning drug does not help patients recovering from moderate and severe Covid – despite this approach being offered to patients.
Call for wider genetic testing for children with brain tumours
A team of doctors at Addenbrooke’s have highlighted how a simple genetic screening test improved the diagnosis and treatment of a little 17-month old girl with a brain tumour – caused by a rare condition.
New hope for kidney cancer treatment
Cambridge researchers have discovered that a drug used to treat lung cancer could potentially help patients with a type of kidney cancer called renal cell carcinoma.
Two top awards for Professor Ravi Gupta
Addenbrooke's doctor and University of Cambridge professor Ravindra Gupta has won the prestigious Translational Microbiology Prize as well as being named as one of the world's most influential researchers of 2022.
Cancer patients to help trial ‘life saving’ home testing kit
Addenbrooke’s hospital is helping to trial a new home-testing device to check if cancer patients are at risk from a serious side effect of chemotherapy.
Medicine for Members: Specialist Palliative Care at CUH - pre, during and post-covid pandemic
the recent developments in the palliative care team in light of the COVID pandemic and how palliative care aims to become a more integrated service across the whole Trust.
Medicine for Members: Specialist Palliative Care at CUH - pre, during and post-covid pandemic
the recent developments in the palliative care team in light of the COVID pandemic and how palliative care aims to become a more integrated service across the whole Trust.
Pledge your support for the East of England’s first dedicated children’s hospital
Sign our form to back Cambridge Children’s Hospital and its unique vision to bring mental and physical healthcare together, with research.
Green Takeover Week: helping tackle climate change
CUH is hosting a ‘Green Takeover’ this week to push forward its commitment to tackle climate change.
Best inventions of 2022: Hologram patients
Medical training developed at Addenbrooke's using hologram patients has been included in Time Magazine's 200 Best Inventions of 2022.
High blood pressure is directly linked to severe Covid
A study led by Addenbrooke’s and the University of Cambridge has shown that people with high blood pressure are more likely to be admitted to hospital and die from Covid, regardless of other factors such as age, sex, ethnicity or BMI.
Lab grown blood given to people in world-first clinical trial
An Addenbrooke's team is involved in a pioneering clinical trial, growing red blood cells in a lab and transfusing them into another person.
Making prostate cancer diagnosis simple, safe and affordable
A new medical device developed at Addenbrooke's hopes to transform the process of diagnosing prostate cancer, making it safer for patients.
You Made a Difference - October 2022
Our winners of You Made a Difference for October 2022 are a specialist nurse and a receptionist.
Awake surgery gives instant results for painful nerve condition
New techniques in awake surgery are being offered to Addenbrooke’s patients to treat a debilitating nerve condition affecting the arms, with almost instant results.
Drive to reduce the environmental impact of medical gases
A team from CUH is leading efforts to reduce the environmental impact of gases used to give pain relief and anaesthesia to hospital patients.
Chimney illuminated to mark festival of light
Addenbrooke’s Hospital has illuminated it’s 220ft chimney to celebrate Diwali.
Trial could ‘transform’ Parkinson’s treatment
Addenbrooke’s will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease.